Puma Biotechnology Inc (PBYI) financial statements (2020 and earlier)

Company profile

Business Address 10880 WILSHIRE BLVD.
LOS ANGELES, CA 90024
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
3/31/2019
Q1
12/31/2018
Q4
9/30/2018
Q3
6/30/2018
Q2
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments112110118150165128135
Cash and cash equivalents605927491086896
Short-term investments525291102576039
Restricted cash and investments9      
Receivables29272581212021
Inventory, net of allowances, customer advances and progress billings3333332
Inventory3333332
Prepaid expense13101112   
Deferred rent asset00     
Other current assets00010211 
Other undisclosed current assets    121212
Total current assets:166151158256203174170
Noncurrent Assets
Operating lease, right-of-use asset1920  
Property, plant and equipment3334444
Intangible assets, net (including goodwill)40414243444546
Intangible assets, net (excluding goodwill)40414243444546
Restricted cash and investments413134444
Other undisclosed noncurrent assets232324323
Total noncurrent assets:69818275565658
TOTAL ASSETS:235232240331259231228
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities88868999675864
Accounts payable1991529211622
Accrued liabilities69777470464241
Debt33     
Other undisclosed current liabilities  22   
Total current liabilities:918892101675864
Noncurrent Liabilities
Long-term debt and lease obligation2323     
Operating lease, liability2323  
Liabilities, other than long-term debt    666
Deferred rent credit    666
Other undisclosed noncurrent liabilities104103126186152121120
Total noncurrent liabilities:127127126186158127126
Total liabilities:217215218288225185189
Stockholders' equity
Stockholders' equity attributable to parent17172243344638
Common stock0000000
Additional paid in capital1,2951,2831,2711,2561,2361,2171,196
Accumulated other comprehensive income (loss)0000(0)(0)(0)
Accumulated deficit(1,278)(1,266)(1,250)(1,212)(1,202)(1,171)(1,157)
Receivable from shareholders or affiliates for issuance of capital stock   (0)  (0)
Total stockholders' equity:17172243344638
TOTAL LIABILITIES AND EQUITY:235232240331259231228

Income statement (P&L) ($ in millions)

12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
3/31/2019
Q1
12/31/2018
Q4
9/30/2018
Q3
6/30/2018
Q2
Revenues63565499716351
Cost of revenue
(Cost of Goods and Services Sold)
  (9)(8)(10)(9)(9)
Gross profit:63564591615442
Operating expenses(72)(71)(80)(89)(90)(74)(92)
Other undisclosed operating income  981099
Operating income (loss):(9)(14)(26)10(19)(11)(41)
Nonoperating expense(2)(2)(12)(20)(12)(3)(3)
Investment income, nonoperating0111110
Other nonoperating income (expense)00(0)(0)(0)(0)(1)
Interest and debt expense (3)(4)(4) (3)(3)
Loss from continuing operations before income taxes:(11)(20)(42)(15)(31)(18)(47)
Other undisclosed loss from continuing operations(0)   (0)  
Loss before gain (loss) on sale of properties:(11)(20)(42)(15)(31)(18)(47)
Other undisclosed net income0  40  
Net loss:(11)(20)(42)(10)(31)(18)(47)
Other undisclosed net income attributable to parent 34  33
Net loss available to common stockholders, diluted:(11)(17)(37)(10)(31)(14)(44)

Comprehensive Income ($ in millions)

12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
3/31/2019
Q1
12/31/2018
Q4
9/30/2018
Q3
6/30/2018
Q2
Net loss:(11)(20)(42)(10)(31)(18)(47)
Comprehensive loss:(11)(20)(42)(10)(31)(18)(47)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(0)350(0)33
Comprehensive loss, net of tax, attributable to parent:(11)(17)(37)(10)(31)(14)(44)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: